Literature DB >> 3350804

Evidence for an organic cation-proton antiport system in brush-border membranes isolated from the human term placenta.

V Ganapathy1, M E Ganapathy, C N Nair, V B Mahesh, F H Leibach.   

Abstract

Uptake of guanidine, an endogenous organic cation, into brush-border membrane vesicles isolated from human term placentas was investigated. Initial uptake rates were manyfold greater in the presence of an outward-directed H+ gradient ([pH]o greater than [pH]i) than in the absence of a H+ gradient ([pH]o = [pH]i). Guanidine was transiently accumulated inside the vesicles against a concentration gradient in the presence of the H+ gradient. The H+ gradient-dependent stimulation of guanidine uptake was not due to a H+-diffusion potential because an ionophore (valinomycin or carbonylcyanide p-trifluoromethoxyphenylhydrazone)-induced inside-negative membrane potential failed to stimulate the uptake. In addition, uphill transport of guanidine could be demonstrated even in voltage-clamped membrane vesicles. The H+ gradient-dependent uptake of guanidine was inhibited by many exogenous as well as endogenous organic cations (cis-inhibition) but not by cationic amino acids. The presence of unlabeled guanidine inside the vesicles stimulated the uptake of labeled guanidine (trans-stimulation). These data provide evidence for the presence of an organic cation-proton antiporter in human placental brush-border membranes. Kinetic analysis of guanidine uptake demonstrated that the uptake occurred via two saturable, carrier-mediated transport systems, one being a high affinity, low capacity type and the other a low affinity, high capacity type. Studies on the effects of various cations on the organic cation-proton antiporter and the Na+-H+ exchanger revealed that these two transport systems are distinct.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3350804

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Guanidine transport in a human choriocarcinoma cell line (JAR).

Authors:  S Zevin; M E Schaner; N P Illsley; K M Giacomini
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

2.  Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1.

Authors:  Tomohiro Terada; Satohiro Masuda; Jun-Ichi Asaka; Masahiro Tsuda; Toshiya Katsura; Ken-ichi Inui
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

3.  Characterization of guanidine transport in human renal brush border membranes.

Authors:  J K Chun; L Zhang; M Piquette-Miller; E Lau; L Q Tong; K M Giacomini
Journal:  Pharm Res       Date:  1997-07       Impact factor: 4.200

4.  Transport of clonidine at cultured epithelial cells (JEG-3) of the human placenta.

Authors:  Johanna Müller; Reinhard Neubert; Matthias Brandsch
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

5.  Characterization of an ATP-driven H+ pump in human placental brush-border membrane vesicles.

Authors:  B J Simon; P Kulanthaivel; G Burckhardt; S Ramamoorthy; F H Leibach; V Ganapathy
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.